CRBU - Caribou Biosciences - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

65.51M

Cash

228.5M

Avg Qtr Burn

-24.31M

Short % of Float

13.10%

Insider Ownership

10.83%

Institutional Own.

73.20%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
CB-011 Details Blood cancer, Cancer, Multiple myeloma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CB-010 Details Non-Hodgkin lymphoma, Cancer, Blood cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.